CDC Endorses Twice-Yearly HIV Prevention Drug Yeztugo, But Access Barriers Remain

In a significant advancement for HIV prevention, the Centers for Disease Control and Prevention (CDC) has issued a strong recommendation for Yeztugo (lenacapavir), Gilead Sciences’ long-acting, twice-yearly pre-exposure prophylaxis (PrEP)…

Continue Reading CDC Endorses Twice-Yearly HIV Prevention Drug Yeztugo, But Access Barriers Remain
Eyedrops Recalled After P. Aeruginosa Infections Killed 3, Injured 65
Source: https://unsplash.com/photos/6F2mPewg2RA

Eyedrops Recalled After P. Aeruginosa Infections Killed 3, Injured 65

  Ezri Care Artificial Tears, as well as nine other ophthalmologic brands that create artificial tears or eyedrops, have been linked to dangerous Pseudomonas aeruginosa infections in people across sixteen different…

Continue Reading Eyedrops Recalled After P. Aeruginosa Infections Killed 3, Injured 65
New Evidence Uncovered Connecting Risk Factors Between Zika Virus and Guillain-Barré syndrome
Source: Pixabay

New Evidence Uncovered Connecting Risk Factors Between Zika Virus and Guillain-Barré syndrome

New findings are coming from a recent study led by researchers at the Journal of the American Medical Association (JAMA) that could have long-term implications for Zika Virus research. Evidence showed that…

Continue Reading New Evidence Uncovered Connecting Risk Factors Between Zika Virus and Guillain-Barré syndrome

How the CDC Opioid Guidelines Might Affect You if You Have Chronic Pain

Whenever it comes to a controversial issue, I always ask myself: Who benefits? In most cases, it’s not all that hard to figure it out. But sometimes, it seems like…

Continue Reading How the CDC Opioid Guidelines Might Affect You if You Have Chronic Pain